Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengyuan Mao

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Stem Cell Research|June 30, 2022
Generation of an induced pluripotent stem cell line (ZZUi036-A) derived from skin fibroblasts of a Neuronal intranuclear inclusion disease patient with GGC repeat expansion in the NOTCH2NLC geneJiadi Li, Yu Fan, Liyuan Fan, et al.
Frontiers in Neurology|October 17, 2022
Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's diseaseHuimin Zheng, Tai Wang, Changhe Shi, et al.
Plos One|August 21, 2015
Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control StudyShuyu Zhang, Changhe Shi, Chengyuan Mao, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 12, 2021
Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and ImmunotherapiesTai Wang, Changhe Shi, Haiyang Luo, et al.
Neuroscience Letters|November 7, 2016
DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han populationChanghe Shi, Fang Li, Jing Yang, et al.
Neural Regeneration Research|May 20, 2024
AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 miceZhengwei Hu, Jing Yang, Shuo Zhang, et al.
Current Neurovascular Research|July 5, 2023
Myasthenia Gravis and Ischemic Stroke: A Bidirectional Mendelian Randomization StudyChen Liu, Chengyuan Mao, Shen Li, et al.
Stem Cell Research|September 22, 2018
Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's diseaseYanlin Wang, Zhilei Wang, Huifang Sun, et al.
Cell Death & Disease|October 24, 2025
Insulin-degrading enzyme confers neuroprotection in Parkinson's disease by inhibiting the Hippo signaling pathwayHuimin Zheng, Yu Guo, Shuyu Zhang, et al.
Stem Cell Research|June 5, 2021
Generation of induced pluripotent stem cell line (ZZUi0021-A) from a patient with spinocerebellar ataxia type 19Fen Liu, Yu Fan, Liyuan Fan, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Stem Cell Research|June 30, 2022
Generation of an induced pluripotent stem cell line (ZZUi036-A) derived from skin fibroblasts of a Neuronal intranuclear inclusion disease patient with GGC repeat expansion in the NOTCH2NLC geneJiadi Li, Yu Fan, Liyuan Fan, et al.
Frontiers in Neurology|October 17, 2022
Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's diseaseHuimin Zheng, Tai Wang, Changhe Shi, et al.
Plos One|August 21, 2015
Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control StudyShuyu Zhang, Changhe Shi, Chengyuan Mao, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|February 12, 2021
Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and ImmunotherapiesTai Wang, Changhe Shi, Haiyang Luo, et al.
Neuroscience Letters|November 7, 2016
DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han populationChanghe Shi, Fang Li, Jing Yang, et al.
Neural Regeneration Research|May 20, 2024
AAV mediated carboxyl terminus of Hsp70 interacting protein overexpression mitigates the cognitive and pathological phenotypes of APP/PS1 miceZhengwei Hu, Jing Yang, Shuo Zhang, et al.
Current Neurovascular Research|July 5, 2023
Myasthenia Gravis and Ischemic Stroke: A Bidirectional Mendelian Randomization StudyChen Liu, Chengyuan Mao, Shen Li, et al.
Stem Cell Research|September 22, 2018
Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's diseaseYanlin Wang, Zhilei Wang, Huifang Sun, et al.
Cell Death & Disease|October 24, 2025
Insulin-degrading enzyme confers neuroprotection in Parkinson's disease by inhibiting the Hippo signaling pathwayHuimin Zheng, Yu Guo, Shuyu Zhang, et al.
Stem Cell Research|June 5, 2021
Generation of induced pluripotent stem cell line (ZZUi0021-A) from a patient with spinocerebellar ataxia type 19Fen Liu, Yu Fan, Liyuan Fan, et al.
Pageof 6